Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $4.30 in the prior trading day, Prime Medicine Inc (NASDAQ: PRME) closed at $4.43, up 2.91%. In other words, the price has increased by $2.91 from its previous closing price. On the day, 0.63 million shares were traded. PRME stock price reached its highest trading level at $4.65 during the session, while it also had its lowest trading level at $4.1599.
Ratios:
Our goal is to gain a better understanding of PRME by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.53 and its Current Ratio is at 2.53. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on April 22, 2024, initiated with a Buy rating and assigned the stock a target price of $17.
On April 03, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $12.Wedbush initiated its Outperform rating on April 03, 2024, with a $12 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 15 ’24 when ARCH Venture Partners XII, LLC bought 3,200,000 shares for $6.25 per share. The transaction valued at 20,000,000 led to the insider holds 3,200,000 shares of the business.
ARCH Venture Partners X, LLC bought 3,200,000 shares of PRME for $20,000,000 on Feb 15 ’24. The 10% Owner now owns 3,200,000 shares after completing the transaction at $6.25 per share. On Feb 15 ’24, another insider, NELSEN ROBERT, who serves as the Director of the company, bought 3,200,000 shares for $6.25 each. As a result, the insider paid 20,000,000 and bolstered with 3,200,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRME now has a Market Capitalization of 530730112 and an Enterprise Value of 401742400.
Stock Price History:
Over the past 52 weeks, PRME has reached a high of $17.20, while it has fallen to a 52-week low of $4.11. The 50-Day Moving Average of the stock is -36.19%, while the 200-Day Moving Average is calculated to be -50.36%.
Shares Statistics:
The stock has traded on average 725.56K shares per day over the past 3-months and 793770 shares per day over the last 10 days, according to various share statistics. A total of 97.38M shares are outstanding, with a floating share count of 49.77M. Insiders hold about 58.50% of the company’s shares, while institutions hold 27.56% stake in the company. Shares short for PRME as of 1713139200 were 10213643 with a Short Ratio of 14.08, compared to 1710460800 on 9666173. Therefore, it implies a Short% of Shares Outstanding of 10213643 and a Short% of Float of 20.599999999999998.
